Skip to main content
PLOS One logoLink to PLOS One
. 2022 Oct 17;17(10):e0274635. doi: 10.1371/journal.pone.0274635

Pharmacotherapy of infertility in Ghana: Why do infertile patients discontinue their fertility treatment?

Stephen Mensah Arhin 1,*, Kwesi Boadu Mensah 1, Evans Kofi Agbeno 2, Diallo Abdoul Azize 2, Isaac Tabiri Henneh 3, Eric Agyemang 4, Charles Ansah 1
Editor: George Vousden5
PMCID: PMC9576038  PMID: 36251650

Abstract

Background

Globally, millions of people of reproductive age experience infertility. With that notwithstanding, most infertile patients undergoing pharmacotherapy withdraw from treatment before achieving the desired outcome. The reasons for their withdrawal, particularly in sub-Saharan Africa, have not been well examined, hence the need for this study.

Objectives

The aim of the study was to examine why infertile patients discontinue pharmacotherapy prior to achieving conception.

Methods

The study employed an exploratory qualitative design. Purposive sampling technique was used to recruit subjects into the study. Twenty infertile patients (fourteen females and six males) who discontinued their treatment, and eight attending health professionals who provided direct care to these patients were interviewed. Telephone and face-to-face interviews were conducted using a semi-structured interview guide. The data collected were transcribed, coded, and generated into themes using thematic content analysis.

Results

The major reasons for discontinuation of infertility treatment included lack of support from male partners, seeking alternative treatment, unmet outcome, poor medical services, distance, stigmatization, and relocation.

Conclusions

Patients and healthcare personnel shared both similar and diverse views on reasons for discontinuation of infertility treatment that reflect situations in a typical African setting, most of which are not reported in existing studies. The outcome of this study will provide insight for fertility therapists and policy makers in designing appropriate measures to facilitate maximum compliance and improvement in treatment outcome.

Introduction

Within developed and developing nations, more than half of infertile couples seek medical care, and follow up on fertility assessment and evaluation [1]. Nevertheless, a significant percentage of couples decide to discontinue fertility care [2]. The prevalence of discontinuation among couples is estimated to be 34% [2], although discontinuation rates may differ across various societies [3].

Seeking treatment for infertility is a stressful situation that may be hampered by factors such as discomfort, complications and failure of medical methods for women [4], cost of treatment [5, 6], psychological burden [7], marital and personal problems [8, 9], perceived poor prognosis, age and parity [7, 10], education and home-to-hospital distance [11]. These prevailing problems mostly lead to appearance of impulsive behaviors, scattered wrath, depression, feelings of helplessness, worthlessness, incompetence, anxiety and negative beliefs towards themselves, which may further worsen the treatment seeking behaviors and outcome of treatment [7, 12, 13].

Additionally, Donkor et al. reported high incidence of lack of concentration, loneliness and decreased sexual satisfaction among infertile women [14]. On the other hand, men suffering from infertility have been found to experience loss of social status, verbal abuse and stigmatization [15].

Infertile patients undergo various forms of treatment, ranging from pharmacotherapy to assisted reproductive technologies such as in vitro fertilization (IVF). Most patients seeking infertility treatment in sub-Saharan African rely on drug treatment, probably due to low socioeconomic status, and limited access to assisted reproductive technologies. Many existing studies in Western countries regarding discontinuation rates mainly concentrate on patients undergoing IVF [2, 7]. However, there is a paucity of studies on reasons for discontinuation by patients undergoing pharmacotherapy for infertility, particularly in sub-Saharan Africa. This is partly due to the fact that most fertility experts/researchers in the sub-region are concerned with positive treatment outcomes, and tend to ignore clients who may decide to stop treatment. Our previous study which assessed the outcome of pharmacotherapy among infertile couples revealed that approximately 19.4% of them conceived after going through drug treatment [16]. However, the retrospective nature of that study made it impossible to assess how clients complied with treatment and the reasons for non-compliance, particularly in the patients who had unsuccessful treatment outcomes. This calls for further study using a prospective approach. As such, between April 2019 and March 2021, a hospital-based survey from four different health facilities was conducted to assess the conception rate among infertile patients undergoing pharmacotherapy for infertility in the Cape Coast Metropolis, Ghana. The 482 patients recruited into the study were followed up for a minimum of 12 months. During the period of follow up, it was observed that some of them discontinued their treatment prior to achieving conception. In order to identify the obstacles such infertile patients encounter during treatment, and to enable stakeholders to develop appropriate interventional strategies that will enhance quality of care, as well as meeting the changing needs of the patients, such reasons ought to be examined. It is against this backdrop that the current study was conducted to assess the reasons for discontinuation of fertility care among infertile patients undergoing pharmacotherapy for infertility in the Cape Coast Metropolis.

Materials and methods

Study design

The study employed an exploratory qualitative design to solicit views from patients and healthcare professionals on the reasons for discontinuation of infertility treatment in Ghana.

Setting

The study was conducted at four different fertility centers in the Cape Coast Metropolis in the Central Region of Ghana. These facilities were selected because they attend to most of the fertility cases within the sub-region and beyond. These facilities also receive referrals relating to fertility issues from health facilities within the Cape Coast Metropolis and from surrounding communities as well.

Sampling

A total of 28 persons were interviewed in this study. These comprised twenty (20) infertile patients who discontinued their treatment (fourteen women and six men) and eight attending healthcare personnel who attended to the patients. The respondents were recruited using purposive sampling technique. Out of the eight healthcare professionals interviewed, four were nurses, and the remaining four were doctors. The health professionals who were actively involved in the management of the patients were purposively selected from each of the four health facilities. The socio-demographic factors of patients and healthcare professionals are represented in Tables 1 and 2 respectively.

Table 1. Socio-demographic data of infertile patients.

Variables Total Gender (range or number)
Age Range N/A Males (29–52 years.); Females (24–43 years)
Discontinuation time N/A Males (1–3 months); Females (2–4 months)
Occupation
Trading 6 Male (1); Females (5)
Teaching 4 Males (2); Females (2)
Farmers 4 Male (1); Females (3)
Fitting Mechanic 1 Male (1); Females (0)
Professionals 5 Male (1); Females (4)
Type of infertility
Primary 14 Males (2); Females (12)
Secondary 6 Males (4); Females (2)
Previous treatment
Yes 12 Males (2); Females (10)
No 8 Males (4); Females (4)

NA = not available.

Table 2. Socio-demographic data of key informants.

Designation Total Gender (number) Average yrs. of infertility care
Doctors 4 Males (3); Female (1) Doctors = 14 years
Nurses 4 Males (0); Females (4), Nurses = 10 years
Total 8 Males (3); Females (5) N/A

Inclusion and exclusion criteria

Patients who complied with treatment and follow up reviews were excluded from the study. Included in the study were patients who skipped review appointments or discontinued treatment prior to achieving conception. Also included were healthcare professionals such as nurses and doctors who offered direct services to these patients.

Data collection

Telephone interviews and Key Informant Interviews (KII) were used to collect the data from respondents. Data was collected by two of the principal investigators from the four fertility centers between September 1st to 31st December, 2021. With the permission of the respondents, interviews were recorded on phone for later transcription.

Conducting of interviews

Telephone interviews were conducted for individual patients at their own convenient time and place using a semi-structured interview guide. The patients were contacted through telephone numbers that were collected on the first day of their visit to the clinic. The purpose of the call was explained to them, and if permission was granted, interviews were carried out. Eight key informant interviews were conducted. This included four nurses and four doctors who were directly involved in the care of the patients. Face-to-face interviews were conducted at the consulting rooms or office of the key informants using a semi-structured interview guide. The interviews were recorded electronically with the consent of the respondents and later transcribed verbatim.

Assigning codes

To ensure the confidentiality of the respondents, the interview transcripts were assigned some serial codes. Thus, interviewees were labeled as Client interviewed Number one (CIN-1), Client Interviewed Number two (CIN-2), up to Client Interviewed Number twenty (CIN-20). Thus, the serial codes begin from CIN-1, CIN-2, CIN-3, CIN-4, and CIN-5… up to CIN-20). Concerning clinical staff, the first interviewee was labeled as Health Practitioner interviewed number one (HP-1), Health practitioner interviewed number two (HP-2), up to Health Practitioner interviewed number eight (HP-8). The outcome of the interview was generated into themes based on the research objectives and questions asked.

Data analysis

The audio-recorded interviews were transcribed verbatim and analyzed using thematic content analysis [17]. To familiarize ourselves with the transcript, we ensured that it was read several times by the principal investigators for clarity. Two of the authors independently coded four (4) of the transcripts (two from the patients and 2 from the healthcare), and the research team compared the outcome to ensure uniformity and reliability of the findings. One of the principal investigators (the first author) then coded all the transcripts using the coding system agreed upon by the research team. A codebook was generated based on the major teams of the study. After identifying the emerging themes and sub-themes, it was then written out in the results. The identified themes and subthemes were then supported with specific quotes from the respondents.

Ethical approval

Ethical clearance was obtained from the Institutional Review Board (IRB) of the University of Cape Coast (Ref No: UCCIRB/EXT/2019), and the Ethical Review Board of the Cape Coast Teaching Hospital (Ref No: CCTHERC/EC/2019). An informed written consent was obtained from all the patients after explaining the objective of the study to them during the initial recruitment stage of the research.

Results

Nine themes were identified from the data. These include husband unsupportiveness, unmet outcome, alternative treatment, financial challenges, poor services, distance, relocation, psychological distress, and stigmatization. Verbatim quotes from the patients and the key informants were used to support the themes and subthemes. The summary of the themes and subthemes obtained from the patients and from the key informant interviews are presented in Tables 3 and 4 respectively.

Table 3. Themes and subthemes from infertile patients.

No Theme Subthemes
1 Husbands’ unsupportiveness Unwillingness to do semen analysis
Men unconcerned because of extramarital affairs
Having children already
2 Unmet outcome Problem still persisting
Delayed conception
3 Alternative treatment Local herbal drugs
Homeopathic clinics
4 Financial challenges Cost of lab investigations
Cost of drugs
Consultation fees
5 Poor services Lack of satisfaction with care
Unavailability of experienced doctors
6 Distance Lack of easy access to fertility centers
Partners not staying at the same place
7 Relocation Work factor
Lockdown
8 Psychological distress Loss of confidence
Constant state of worrying
Emotionally traumatized

Table 4. Themes and subthemes from key informant interviews.

No. Themes Subthemes
1 Husbands’ unsupportiveness Unwillingness to do semen analysis
Less concerned about the problem
2 Unmet outcome Delayed outcome
Lack of expected results
3 Financial challenges Cost of lab investigations
Cost of drugs
4 Distance Fertility centers situated in cities and work on special days
Most travel from far rural areas
5 Stigmatization Social isolation
Societal pressure

Why do infertile patients discontinue treatment?

This section presents the qualitative findings on the issue of why some patients discontinue treatment or skip review appointments with clinicians.

Husband unsupportiveness

With regard to why patients discontinue treatment or review appointments with clinicians, some of the respondents said their husbands do not adhere to treatment. This is typical of a society where women are mostly and unjustifiably held responsible for childlessness. Accounts of why most infertile patients discontinued treatment due to apathy on the part of the male partners were common. The women were mostly left stranded to seek their own care because the male partners see themselves as ‘strong’ and ‘fit’ to reproduce. For instance, CIN-2 disclosed the refusal of her husband to come for investigation, as she said:

Is my husband oo, he did not want to come and do the test.

CIN 11 also shared a similar view on her discontinuation of treatment by saying:

When the doctor initially told my husband to come and do semen analysis, he said that, his sperms are okay.

Again, most of the interviewees recounted that, their husbands do not want to adhere to treatment and come for diagnostic investigations because they already have children. A quote from CIN- 10 recounts:

We are not divorced but is being a while that we saw each other. Is like he doesn’t stay at one place. I have been trying that, things will work for me. As for him, he has children. That is it. I am the only person trying hard to get the solution.

Similarly, CIN-11 reiterates:

You know the men, when they are able to impregnate one or two women, they think that, everything about them is correct. He thinks that is my own problem and I am the cause so I should seek my own help.

CIN-3 also shared a similar view when she disclosed:

My husband said he will come but he is doing some style. He has also relaxed because he already has two children.”

In a similar view, CIN-19 also recounted:

My husband is always finding excuse to come with me. When I came the first day, the doctor wrote some labs for me to do. He informed me that, my husband has to come for some test. When I went home and I informed him about it, he said he will come but always finding excuses. I can see that; he does not care so much because he has a child already. It seems I am much concerned about the situation than my husband.

Another woman (CIN-20) also reiterated how uncooperative her husband was although she does not seem to know why her husband was doing that.

She said:

Hmmm. My husband is doing himself some way. As if he is not interested in the marriage anymore because of the problem. He shows less concern about seeking care. Now it seems I am giving up. Yes. Is a big challenge but what can I do?

Unmet outcome

Another dimension disclosed by the patients that influenced them to discontinue treatment was the lack of expected outcome. The key expectation of patients seeking infertility treatment is conception and live birth. Anything short of that is not tolerated as most of them do not want to waste their time.

CIN-1 narrates her ordeal as she said:

I was not seeing any results. I came several times but the problem was persisting. When you start with expectation and you do not see the outcome, it becomes worrying.

In a similar account, CIN-11 added:

I have been coming severally but nothing is coming so I have closed my mind small. When the doctor gives me the drugs, my menses sometimes delay, thinking that I may be pregnant. But when I check for pregnancy, there is nothing there.

CIN-12 and CIN-19 also shared similar views as they recounted a delay in achieving conception as the major reason for discontinuation of treatment.

Alternative treatment

Another key reason that contributed to discontinuation of treatment was seeking of alternative treatment (e.g. local herbal medications). Responses from CIN-5, CIN-6, and CIN-19 suggested that they discontinued their visit to the clinics because they wanted to try complementary and alternative treatment. For instance, CIN-5 said:

We went to herbal clinic. The medicine that they prescribed we wanted to finish with it before we consider going back to the hospital”.

CIN-6 also revealed:

I stopped and went to Accra to see specialist (name of facility withheld). I went there too, as well as (name of facility withheld). I later came back for the specialist to see me again. I wanted to try their system too.

The use of local herbal medications was another reason that was shared when CIN-1 said:

I resorted to herbal medicine. When you start with expectation and you do not see the outcome, it becomes worrying. For that reason, I switched to herbal treatments.

Financial challenges

A major factor that also influenced some of the patients to discontinue treatment was financial difficulties. Most of the patients (CIN-4, CIN-10, CIN-12, CIN-13, CIN-14, and CIN-18) recounted their challenges with regards to finances. For example, CIN-4 disclosed:

It is because of money that is why we stopped coming. We paid a lot of money the last time we came. We did a lot of investigations but doctor said he cannot identify what is wrong with me so we need to do other investigations somewhere. But before the investigation is done, we needed to pay Gh₵ 1000 but we did not have the money. That is why we stopped coming although the problem is not solved.

CIN-4 further noted with regards to the facility charges by saying:

We have to pay for consultation fees even if we are going for review. They treat us like new patients all the time.

Additionally, CIN-8 also complained about expensive drugs within the facility when he revealed:

I had a little problem at the dispensary. The drugs. You see. The price at the facility is too much. It is something that put most of the customers off.

In a similar manner, CIN-13 added:

Hmmm. My problem has been there for quite some time now. I have spent a lot of money on it. But unfortunately for me, I am just a farmer and do not have too much money. I only come when I have been able to gather some enough money from my farm proceeds. When the money gets finished, I have to suspend my coming until I have been able to raise some money again. As we are speaking now, like you asked me, my time for review has passed but I don’t have the means to come. I am even in the farm right now even though the problem is not solved.

CIN-18 additionally shared his view on financial challenges when he said:

My major challenge has been finances. We need to pay for services anytime we come. Besides, we come from a very far place, so coming with my partner requires a lot of money. Sometimes, when the medications are written for us, we are unable to buy all. That is our main reason for not coming.

Poor services

Other interviewees (CIN-5, CIN-8, and CIN-17) also recounted lack of satisfaction with care as the common reason for termination of treatment. For instance, CIN-8 recounted:

They keep changing the doctors that come there. Today this person will come and they change him. Tomorrow this person will come and they change him too. You call the doctor and he respond ‘I am in Accra’. You call this person and he says ‘ooh I have been transferred’. We were not happy coming there again because errm one person sees your problem and works on it. But the doc who is taking care of us, we call him today I am not there, we call him and he says I am not there.

CIN-8 additionally shared his view on lack of experienced doctors as the reason for discontinuation by saying;

Is like try try try. Small children try try. The students and erh so you see the service is not all that good. You see, is like UCC students who attend to us so you will not get gynecologist who is responsible for such issues to attend to you the way you want. The students will be asking you some things like, you see, the things they ask is like noo. Is not all that convincing.

Similarly, CIN-17 added his views on how change of doctors affected his compliance with treatment when he narrated:

Initially I had conviction that, since is a big hospital, I will have better services. But sometimes when you come, you see that the services are not all that good. It did not meet my expectation. Sometimes you need to come as early as possible because of distance but after waiting for a number of hours, then you are told that the doctor will not come. So, you see, you become so disturbed. When you are lucky to have a new person, he may not be experienced as you wish. Yes. So that was my problem. It happened on two occasions that is why I decided not to come again.

CIN-5 also shared another view when she questioned the treatment option that was given to her husband without providing additional alternatives. She said:

We have not been coming because the option that they were giving my partner, is like I was not satisfied with it. That they may operate on him. So, I wanted to see if there is any other hospital that I will get another option like given of medications instead of the surgery to improve his situation.

Distance

Another factor that affected patients’ cooperation with treatment was distance. Some of the patients stay far from the treatment centers, as they travel from the outskirts of the city to access the fertility clinic. CIN-18 recounted his challenges when he said:

We come all the way from Praso so is not easy to follow all the orders they give us. That is not our wish though, but if for any reason, we delay a bit, then we have to suspend our coming because we may not meet the doctor when we get there late.

In a similar account, CIN-14 said:

My place is very far and I need to come early too. So sometimes when I get to know that I am late, I don’t come at all. This is because when I come and they have finished receiving cards for that day, I have to go back without seeing the doctor.

Another issue with regards to distance was when one of the partners stayed at a different place. This made it very difficult for them to come together when it was required. For instance, CIN-15 reiterated:

I came alone the first day. The doctor told me to bring my partner but he is not here. He works in different region and comes here some weekends. You know the hospital does not attend to us on weekends. I have decided to go there so that we can see a doctor at where my husband works.

Relocation

In other views, CIN-7 and CIN-9 attributed their discontinuation to lockdown or relocation to different region. CIN-7 indicated:

My review time happened to be in the lockdown period. More so I have relocated from Cape Coast to Kumasi. So apart from the lockdown, relocation also affected our ability to come for review again.

CIN-9 also recounted similar by saying:

At the moment we are not even at Cape Coast anymore. But we will try and come again. we have moved away from Coast because of work.

Psychological distress

Most of the respondents were subjected to psychological distress which affected their treatment seeking behaviors. Some of the patients with psychological distress (CIN-9, CIN-10, CIN-11, and CIN-12) shared similar views on how the situation worried them. CIN-1 shared her view about loss of confidence when she stated:

It is not easy at all. Sometimes we are psychologically down and lose confidence. That is why coming for review is sometimes difficult for us. We are only praying that, we will be able to overcome the situation.

CIN-4 indicated a constant state of worrying as he added:

We get so worried sometimes. You see, you try to take your mind of it and concentrate on what you are doing. But as you try to focus, your attention is shifted to it from time to time.

CIN-8 aired his views about being emotionally traumatized:

Emotionally we are down because what we are expecting, we are not getting. That put us off. We are worried as it seems things are delaying. This is not the first time we are seeking care but the situation is the same. Is like we should give up.

The response from the interviewees show that they have diverse reasons for discontinuation of treatment at fertility clinics.

Health practitioners’ responses on why patients discontinue treatment

Cost of treatment

One of the major reasons’ why patients discontinued infertility treatment as indicated by the Key Informant Interviewees (health practitioners) is financial challenges. Almost all the interviewees mentioned financial difficulties as a common reason for discontinuation of infertility services. For example, HP-1 stated:

As for the reasons, is mostly because of money issues. Lack of funds to pursue the investigations and treatment is one of the main reasons they discontinue treatment.

Another account from HP-4 indicated:

Most of them have financial challenges. The investigations and treatment are very expensive. This tend to put many of them off after they have started the whole process.

Similarly, HP-5 also stated:

They always complain of expensive investigations and cost of medications. That is why most of them discontinue with treatment

HP-8 also reiterated his view when he said:

Another reason is the cost of treatment. You know, national health insurance does not cover the services so the clients bear all the cost. Is something that can put them off.

Husbands’ unsupportiveness

Another reason the health practitioners emphasized was lack of support from the male partners. Most of them (HP-1, HP-3, HP-4, HP-6) indicated that the male partners refuse to support the women in seeking care.

For instance, HP-1 said:

Second one is unwillingness of the husbands to come and do investigation. Like you ask them to come for semen test and they don’t show up. That is it.

In a similar way, HP-6 also indicated:

Some of the men don’t really support the women. They refuse to come for the investigations. That is why most of them are not able to continue with treatment.

HP-4 also recounted:

Another reason is also lack of cooperation from male partners. They fail to come along with the women. The doctors are supposed to assess them together so if they don’t show up, it demoralizes the women so they end up not coming again.

Unmet outcome

An important reason that caused clients to terminate care was a delayed outcome of treatment. Interviewees (HP-3, HP-6, HP-8) indicated that the delay in achieving expected outcome is a major factor that contributes to discontinuation of care.

For example, HP-3 stated:

The main reason is because they are fed up. Since they don’t see better result after coming for some time, they tend to give up. When this happens, they don’t come again at all.

HP-8 also shared his view when he indicated:

What I can say is that most of them want instant results. But is a process so they easily give up. Most of them do not have the patience to wait for long. To some of them, the mere fact that they have come for treatment and within some few days they are not seeing results as expected, they tend to give up.

In a similar way, HP-6 recounted:

Some of them too, when they come and they don’t achieve the results as expected, they give up. So not seeing desired results is an important factor that affects their compliance with health.

Long distance

Long distance also accounts for a common reason why patients discontinue treatment. Some of them have to travel from far places within the region, and sometimes beyond to seek care. Some of the respondents (HP-2, HP-7, HP-8) shared their views on how distance affects the way patients adhere to treatment.

For example, HP-2 stated:

One of the main reasons I think clients don’t come is because of distance. You know, some of them come all the way from Takoradi and other far places. That is one of the hinderances for them.

HP-7 also said:

I think distance might be a contributing factor. Some do come from far places. You know our clinics operates once in a week, so if by any reason, anything should come across them, they are not able to come as expected.

In a similar way, HP-8 also shared his views when he indicated:

The third reason is distance. No access to it where they live, especially those in rural areas. They have to travel all the way to the city to access these services since is not available over there.

Stigmatization

Stigmatization was one of the important reasons for discontinuation of infertility treatment, as shared by health professionals. Most of them do not feel comfortable when others get to know that they are seeking treatment for infertility. For instance,

HP-8 shared his view when he said:

They feel stigmatized. They feel people will be asking them why they are always going to hospital, and what is wrong with them.

Similarly, HP-5 also stated:

What I can say is that, most of them don’t always feel comfortable coming for treatment. They don’t want some of the people close to them to know that, this is what they are suffering from. They think that others will be gossiping about them. This forces some of them to seek care at places far from where they live or work. As you might be aware, some of them already feel the pressure of social stigma.

The above responses from health practitioners were shared as the common reason why infertile patients usually discontinue treatment.

Discussion

The study was conducted to explore the views of patients and healthcare professionals on the reasons for discontinuation of fertility care by infertile patients prior to achieving conception. It analyses the data critically with reference to relevant literature in an attempt to explore deeper meanings of the responses, to unravel the issues and understand the phenomenon. Among the healthcare professionals interviewed were doctors and nurses from the four fertility centers who provided direct care to the patients. The respondents expressed diverse views on the factors that influenced discontinuation of infertility treatment in Ghana, which were not discovered in our previous study since it relied on secondary data [16]. It is evident from this qualitative study that patients who discontinued treatment cited various reasons to back their actions. Despite the major overlaps of responses, there were slight differences with regards to the reasons disclosed by the patients and the healthcare professionals. The findings revealed that, although various fertility clinics exist to ensure that the needs of infertile couples are met, there were inherent challenges that hindered patients from seeking treatment. Among the major challenges included the lack of cooperation from male partners, not achieving the expected outcome, adoption of alternative treatment, financial challenges, poor satisfaction with care, and relocation or lockdown as part of the COVID-19 restrictions. Given the psychological distress and stigma attached to infertility, and other negative socio-cultural consequences that infertile patients experience in Ghana [18], immediate intervention is required to rectify such challenges.

Several studies have attempted to understand why patients discontinue fertility treatment, with psychological burden cited as one of the most common reasons for discontinuation [2, 19]. However, in the current study, one of the major factors that influenced the patients to discontinue treatment, as recounted by patients, and healthcare professionals, was the non-cooperation of male partners. Such attitudes of the men create a problem during the assessment and evaluation of infertile couples, owing to the fact that men and women contribute approximately equally to the causes of infertility [20]. Despite these findings, in many parts of the world, both men and women are unlikely to attribute infertility to the male partner, a factor that is believed to contribute to the low patronage of men in seeking fertility treatment [21]. In sub-Saharan Africa, especially Ghana, there is a high social perception that women are responsible for infertility among couples [22]. This is true for most African countries, where there is a strong cultural perception and the belief that African men do not become infertile [23]. This perception makes most men feel relaxed about taking important steps towards seeking treatment. It is important to know that failure of any of the partners to avail themselves for evaluation may hinder the entire treatment process and outcome. Given the fact that the diagnosis and treatment of infertility requires the cooperation of both partners, it remains imperative to put in appropriate measures that will address such challenges.

The uncertainty and perceived delay in treatment outcome also served as an important reason for discontinuation of fertility treatment. Expected treatment outcome (pregnancy and live birth), remains the ultimate desire of infertile patients undergoing pharmacotherapy for infertility. In Ghana for instance, new couples struggling with infertility are constantly pressured and stigmatized by their extended families and the community. This compels the majority of the couples to seek early treatment to avert the situation. However, the unmet expected outcomes for an ongoing treatment could easily result in apathy and discontinuation of treatment since they become psychologically distressed. This finding is in line with reports in existing literature, which indicate that the sense of futility associated with treatment [8, 24], and perceived poor prognosis and psychological dilemma [7], contribute to discontinuation of therapy. Although the evaluation and treatment of infertile patients may be cumbersome, and treatment outcome mostly depends on the cause of infertility, many patients do not see it that way. To most of them, a delayed outcome means a treatment failure, hence the need to seek alternative treatment. Usually, such couples begin to seek alternative treatments elsewhere, aimed at finding better and immediate solutions to their predicament. Extensive education prior to, and during the cause of treatment is very important to ensure that infertile patients comply with treatment.

It is therefore not surprising that most of the patients discontinued treatment with the intention of finding alternative solutions to their problem, as identified in the current study. Against the backdrop that infertility is a highly stigmatized and unacceptable condition in many communities in Ghana [22], seeking alternative treatment is a common practice among such patients. Numerous treatment options are being tried, including local concoctions, spiritual consultations, etc. It has become common practice to use local herbal medicines, as many native doctors claim to have an immediate cure for infertility. In line with this finding, widespread usage of local herbal medications among infertile couples has been reported in some parts of Africa [25, 26]. Similarly, it has been reported that some infertile women undergoing treatment abandon their treatment and resort to herbalists to drink some herbs in order to be cleansed from superstitious powers, which they perceive to be the cause of their fertility problems [27]. However, in most instances, seeking multiple treatment from different sources offer very little in terms of solving the problem. Therefore, extensive counseling of infertile couples, before and after commencing treatment is required, as most of them take such decisions out of desperation. Moreover, seeking fertility care in sub-Saharan Africa is very expensive due to the long-standing investigations and cost of medications. Hence, delayed, or unmet treatment outcome, may put further financial burden on such couples, which may subsequently cause them to discontinue treatment [28, 29].

Access to fertility clinics may also influence how infertile couples adhere to treatment [5]. In Ghana for instance, most of the fertility clinics are centralized in the major cities such as the regional capitals. Staying far from such cities, or relocation to places other than those major cities could make it difficult for them to access such services, as this may put further financial burden on the patients. Consequently, childless couples who are unable to travel to such areas to access fertility clinics usually resort to local herbal practitioners for treatment.

In view of the high number of infertility patients who have experienced failed treatments at fertility clinics, and the stress associated with seeking treatment, it has become imperative for fertility centers to meet the demands and primary needs of infertile couples. The current study revealed that some of the patients were not happy about the services they received at some health facilities. This subsequently led to the discontinuation of treatment, and this is consistent with other findings about patients suffering from other conditions [30]. The perceived lack of experienced doctors was one of the major factors that affected their satisfaction with care, which was common in the state-owned facilities. Maintaining competent and experienced workers is necessary in meeting the needs of infertile couples who may already be traumatized emotionally.

Although stigmatization was mentioned by the health practitioners, the fertility patients scarcely voiced out anything regarding stigma as the cause of discontinuation of infertility treatment. It has been reported that, infertile women who involved themselves in seeking treatment experienced minimal levels of perceived stigma [31]. In the current study, all the respondents had availed themselves for treatment at some point in time, suggesting that such patients were less concerned about perceived stigma or infertility related stigma. Hence, not voicing it out as one of their major concerns. Another probable reason could be that some of the infertile patients, who might have discontinued their treatment due to perceived stigma, did not know how to voice it out, hence the complete omission of stigmatization from their responses.

Stigmatization, as recounted by the healthcare professionals, also contributes to discontinuation of infertility medical services. Children are highly valued in Ghana such that voluntary childlessness is not even welcomed. This compels many infertile couples to often seek early treatment before the general public become aware of their predicament. However, the use of some special places or days for fertility clinics make most infertile couples uncomfortable, as they may be easily tagged by some health professionals, as well as people within their community who may be aware of dates and times for such services [22]. More importantly, infertility in Ghana is usually managed by the obstetrician gynecologist at designated places within the hospital which are mostly overcrowded with a lot of female patients and nurses. Sometimes, in the midst of many women, one male patient is noticed sitting among them, so the reason for their presence at such places becomes so obvious. As such the environment may be intimidation and this may discourage most men from visiting fertility clinics, especially state-owned facilities. Adequate measures are therefore needed to provide standardized treatment procedures that will reduce exposure of clients to stigmatization.

Strength and limitations of the study

Relatively few male partners agreed to participate in the study, even though their responses were much needed, given the fact that they were mostly uncooperative with treatment. However, the semi-structured interview guide enabled detailed information sharing which adequately brought out the key issues. Again, the health professionals who served as key informants provided useful information from another perspective that augmented the information provided by the patients.

Conclusion

From the current study, patients and healthcare professionals shared both similar and diverse views on reasons for discontinuation of infertility treatment. Failure to address these factors could negatively impact treatment outcome, which may therefore worsen the psychological distress of infertile couples. Counselors of such couples are therefore required to engage both partners on the need for active participation in the treatment process in order to ensure positive outcome. Additionally, it will be prudent for fertility clinics to increase efforts at attracting and retaining highly qualified and experienced staff to enhance compliance with treatment.

Supporting information

S1 File

(DOCX)

Acknowledgments

The authors wish to express their profound gratitude to all respondents who availed themselves for this study. We also wish to thank the management of the various fertility centers for making their facilities available for this research.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod. 2007;22(6):1506–12. doi: 10.1093/humrep/dem046 [DOI] [PubMed] [Google Scholar]
  • 2.Domar AD, Smith K, Conboy L, Iannone M, Alper M. A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment. Fertil Steril. 2010;94(4):1457–9. doi: 10.1016/j.fertnstert.2009.06.020 [DOI] [PubMed] [Google Scholar]
  • 3.Rajkhowa M, McConnell A, Thomas G. Reasons for discontinuation of IVF treatment: a questionnaire study. Human Reprod. 2006;21(2):358–63. doi: 10.1093/humrep/dei355 [DOI] [PubMed] [Google Scholar]
  • 4.Bakhshayesh AR, Kazeraninejad M, Mongabadi MD, Raghebian M. A comparison of general health and coping strategies in fertile and infertile women in Yazd. Iran J Reprod Med. 2012;10(6):601. [PMC free article] [PubMed] [Google Scholar]
  • 5.Mosalanejad L, Parandavar N, Abdollahifard S. Barriers to infertility treatment: an integrated study. Glob J Health Sci. 2014;6(1):181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kenneth JR, Ryan K, Berkowitz R, Barbieri R, Dunaif A. Kistnerfs Gynecology and Womens Health. Marie-Andree, ed 7th, Mosby. 1999:580–604. [Google Scholar]
  • 7.Brandes M, Van Der Steen J, Bokdam S, Hamilton C, De Bruin J, Nelen W, et al. When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population. Human Reprod. 2009;24(12):3127–35. [DOI] [PubMed] [Google Scholar]
  • 8.Olivius C, Friden B, Borg G, Bergh C. Why do couples discontinue in vitro fertilization treatment? A cohort study. Fertil Steril. 2004;81(2):258–61. doi: 10.1016/j.fertnstert.2003.06.029 [DOI] [PubMed] [Google Scholar]
  • 9.Verberg M, Eijkemans M, Heijnen E, Broekmans F, de Klerk C, Fauser B, et al. Why do couples drop-out from IVF treatment? A prospective cohort study. Human Reprod. 2008;23(9):2050–5. doi: 10.1093/humrep/den219 [DOI] [PubMed] [Google Scholar]
  • 10.Pearson KR, Hauser R, Cramer DW, Missmer SA. Point of failure as a predictor of in vitro fertilization treatment discontinuation. Fertil Steril. 2009;91(4):1483–5. doi: 10.1016/j.fertnstert.2008.07.1732 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Pedro J, Sobral MP, Mesquita-Guimarães J, Leal C, Costa ME, Martins MV. Couples’ discontinuation of fertility treatments: a longitudinal study on demographic, biomedical, and psychosocial risk factors. J Assist Reprod Genet. 2017;34(2):217–24. doi: 10.1007/s10815-016-0844-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Covington SN, Burns LH. Infertility counseling: A comprehensive handbook for clinicians: Cambridge University Press; 2006. [Google Scholar]
  • 13.Gameiro S, Boivin J, Peronace L, Verhaak CM. Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment. Hum Reprod Update. 2012;18(6):652–69. doi: 10.1093/humupd/dms031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Donkor E.S., Naab F. and Kussiwaah D.Y. “I am anxious and desperate”: psychological experiences of women with infertility in The Greater Accra Region, Ghana. Fertil Res Pract. 2017;3(1): 1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Dyer S.J., Abrahams N., Mokoena N.E. and van der Spuy Z.M. ‘You are a man because you have children’: experiences, reproductive health knowledge and treatment‐seeking behaviour among men suffering from couple infertility in South Africa. Hum Reprod. 2004;19(4): 960–967. doi: 10.1093/humrep/deh195 [DOI] [PubMed] [Google Scholar]
  • 16.Arhin SM, Mensah KB, Agbeno E, Badii VS, Ansah C. Pharmacotherapy of infertility in Ghana: retrospective study at the Cape Coast teaching hospital. J Pharm Policy Pract. 2019;12(1):1–10 doi: 10.1186/s40545-019-0191-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hsieh H.F. and Shannon S.E. Three approaches to qualitative content analysis. Qual Health Res, 2005;15(9): 1277–1288. doi: 10.1177/1049732305276687 [DOI] [PubMed] [Google Scholar]
  • 18.Oti-Boadi M, Oppong Asante K. Psychological health and religious coping of Ghanaian women with infertility. Biopsychosoc Med. 2017;11(1):1–7. doi: 10.1186/s13030-017-0105-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Van den Broeck U, Holvoet L, Enzlin P, Bakelants E, Demyttenaere K, D’Hooghe T. Reasons for dropout in infertility treatment. Gynecol Obstet Invest. 2009;68(1):58–64. doi: 10.1159/000214839 [DOI] [PubMed] [Google Scholar]
  • 20.Deshpande PS, Gupta AS. Causes and prevalence of factors causing infertility in a public health facility. J Hum Reprod Sci. 2019;12(4):287. doi: 10.4103/jhrs.JHRS_140_18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Dhont N, Luchters S, Ombelet W, Vyankandondera J, Gasarabwe A, Van de Wijgert J, et al. Gender differences and factors associated with treatment-seeking behaviour for infertility in Rwanda. Hum Reprod. 2010;25(8):2024–30. doi: 10.1093/humrep/deq161 [DOI] [PubMed] [Google Scholar]
  • 22.Tabong PT-N, Adongo PB. Understanding the social meaning of infertility and childbearing: a qualitative study of the perception of childbearing and childlessness in Northern Ghana. PLoS One. 2013;8(1):e54429. doi: 10.1371/journal.pone.0054429 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Naab F. Every month becomes a funeral when they menstruate: African women’s beliefs about couple infertility. J. Infertil Reprod Bio. 2014;2(3):92–100. [Google Scholar]
  • 24.Smeenk JM, Verhaak CM, Stolwijk AM, Kremer JA, Braat DD. Reasons for dropout in an in vitro fertilization/intracytoplasmic sperm injection program. Fertil Steril. 2004;81(2):262–8. doi: 10.1016/j.fertnstert.2003.09.027 [DOI] [PubMed] [Google Scholar]
  • 25.Kaadaaga HF, Ajeani J, Ononge S, Alele PE, Nakasujja N, Manabe YC, et al. Prevalence and factors associated with use of herbal medicine among women attending an infertility clinic in Uganda. BMC Complement Altern Med. 2014;14(1):1–6. doi: 10.1186/1472-6882-14-27 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.James PB, Taidy-Leigh L, Bah AJ, Kanu JS, Kangbai JB, Sevalie S. Prevalence and correlates of herbal medicine use among women seeking Care for Infertility in Freetown, Sierra Leone. Evid Based Complement Alternat Med. 2018;2018. doi: 10.1155/2018/9493807 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Dyer S.J., et al. Infertility in South Africa: women’s reproductive health knowledge and treatment-seeking behaviour for involuntary childlessness. Hum Reprod, 2002;17(6): 1657–1662. doi: 10.1093/humrep/17.6.1657 [DOI] [PubMed] [Google Scholar]
  • 28.Eisenberg ML, Smith JF, Millstein SG, Nachtigall RD, Adler NE, Pasch LA, et al. Predictors of not pursuing infertility treatment after an infertility diagnosis: examination of a prospective US cohort. Fertil Steril. 2010;94(6):2369–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Goldfarb J, Austin C, Lisbona H, De Mola RL, Peskin B, Stewart S. Factors influencing patients’ decision not to repeat IVF. J Assist Reprod Genet. 1997;14(7):381. doi: 10.1007/BF02766144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Casado J, Marín A, Romero V, Banon S, Moreno A, Perez‐Elías M, et al. The influence of patient beliefs and treatment satisfaction on the discontinuation of current first‐line antiretroviral regimens. HIV Med. 2016;17(1):46–55. doi: 10.1111/hiv.12280 [DOI] [PubMed] [Google Scholar]
  • 31.Naab F., Brown R., and Heidrich S. Psychosocial health of infertile Ghanaian women and their infertility beliefs. J. Nurs Scholars. 2013;45(2):132–140. doi: 10.1111/jnu.12013 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Olujide Olusesan Arije

7 Jun 2022

PONE-D-22-12329Pharmacotherapy of infertility in Ghana: Why do subfertile couples discontinue their fertility treatment?PLOS ONE

Dear Dr. Arhin,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. In addition to comments provided by the two reviewers, the please consider the following:

Line 26: Consider revision to "The study employed an exploratory qualitative design"

Line 26-26: It is enough to say "purposive sampling technique"

Line 28: Write ‘8’ in word

Line 29: Consider changing "were sampled and interviewed" to just "were interviewed"

In the abstract, state the data analysis approach in a short sentence.

Line 32: Consider revising to: “The major reasons for discontinuation of infertility medical services included….”

Line 37-39: It might be better to say the insight provided rather that say it will provide insight. The current statement sounds like a justification for the study, not a recommendation from the findings, as might be the intention of the authors.

Line 94: This initial statement does not make your study population clear. Twenty couples ordinarily means 20 pairs of persons, making 40 persons. Also, please indicate that you did not interview both members of each couple pair, and why not.

Please ensure to remove any personal identifying information from your manuscript, including names of organizations where identifying them is not essential to the information being provided. You must justify the inclusion of names that identify any entity.

Concerning your suggestions on the approach to data collection, infertility is a sensitive issue and FGD may still not be the most appropriate fora for data collection, particularly when the proposed participants are currently experiencing infertility.

In line with the comments of one of the reviewers, consider removing the word "subfertile" from your title.

Do pay attention to typographical and grammatical errors.

Please submit your revised manuscript by Jul 22 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Olujide Arije

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is an interesting paper which focuses specifically on pharmacotherapy for sub-fertile couples in Ghana and why these couples may discontinue treatment before achieving pregnancy.

In the title you talk about choices that subfertile couples make, but I am not sure how representative the term couples is of the study population?

Some small changes which would make some things clearer for me:

line 72, pg 4 - change to 'for infertility' instead of 'of infertility'

line 73, pg 4 - add Metropolis to Cape Coast, as you later refer to just 'the metropolis' this confused me, and then you later call it Cape Coast Metropolis

line 76, pg 4 - to enable stakeholders 'to' develop (word missing)

lines 94-96, pg 5 - I would like to see this more clearly, on first reading it appears you interviewed 20 couples, but you then say you interviewed 14 women and 6 men. Maybe be specific that you interviewed 20 clients, which were a combination of 14 women and 6 men - but were any of these couples?

line 130 - pg 7 - who did the transcription? and also did you use a specific type of thematic analysis?

line 132, pg 7 - reword 'two of the authors coded few' this reads as though they coded a minimal amount - might be useful to say how many and which (HCP or clients)

line 135, pg 7 - It feels more accurate to say that themes were identified than that they emerged.

line 138, pg 8 - I think you mean that you were maintaining confidentiality, the opposite to disclosing the identity of the participants?

line 190, pg 10 - 'live' birth (also line 430)

line 433, pg 21 - you talk about internal and external pressures - which do you mean specifically?

line 485, pg 24 - midst, not mist

I really enjoyed reading this, thank you. And I think you have made some really important points, particularly about the abdication of responsibility of the male partners.

There has been much made of the 'delay' to treatment outcomes - do you have a sense, or data to indicate what sort of time frames that are contributing to the drop out of treatment?

I think that this article may need some editing for language and clarity, but the data support the conclusions and suggestions you have made for how services could be improved.

Reviewer #2: Review PONE-D-22-12329

This a very important qualitative interview study on why couples in Ghana discontinue fertility treatment (pharmacotherapy). A topic where we have very limited knowledge from low/middle income countries. Globally, infertility is one of the most frequent diseases among reproductive-aged women and men. In middle and low-income countries the access to fertility treatment is limited and is not affordable for many couples with infertility. The study is carefully conducted, data clearly presented and the manuscript is easy to follow.

I have a number of minor suggestions –

Terminology

I suggest to follow the terminology in the International Glossary on Infertility and Fertility Care, 2017 (Zegers-Hochschild et al., Human Reproduction, 2017). My suggestion is to use “infertility” as this is clearly defined (and not “subfertility” that is usually not well-defined); fertility care, fertility clinics, fertility treatment and in line with this fertility patients.

Throughout the manuscript is used both “clients” and “fertility patients”. I suggest to use only one term (fertility patients). Similarly, is used both “infertility” and “subfertility”. I suggest infertility as stated above.

Introduction

is well-written and provides a good overview. I suggest to include a few more papers on infertility in Sub-Saharan countries. Search e.g., for papers in Pubmed published by Silke Dyer, Johanne Sundby, Florence Naab and others and you will find papers e.g., on access to fertility care, the psychosocial impact of infertility, studies on the impact of male infertility, how fertility patients assess treatment. Some could probably also be included in the Discussion section.

Materials and methods

I suggest to add either a table or a short overall description of the study participants (besides their gender). For the fertility patients – e.g., age range, previous reproductive history (have child/children or not), previous treatment. For the health care professionals – e.g, number of years in fertility care. This info should be provided on a group level, so the study participants could not be identified.

I suggest to put the paragraph on Ethical approval as the last section before Results.

Please, provide a reference to the thematic analysis used.

The description of how you assigned codes to the interview transcripts is not a Result and should be placed in the M&M section.

Results

I suggest you provide a table showing themes from interviews with fertility patients and with health care professionals, respectively. To help the reader to have an overview.

Otherwise the result section is easy to follow and quotes selected are illustrative for the theme.

In quotes, I would recommend not to mention e.g., name of fertility clinics in order not to reveal study participant identity.

I would prefer Psychological distress (p. 15 , line 299) instead of disturbances (which sounds closer to psychiatric disorders).

Discussion is relevant. I found it interesting that the fertility patients’ do not mentioning stigma as a reason for discontinuation, but it was mentioned by the health care professionals. Could this difference be discussed in short?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Eleanor Molloy

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Oct 17;17(10):e0274635. doi: 10.1371/journal.pone.0274635.r002

Author response to Decision Letter 0


19 Jul 2022

RESPONSE TO EDITOR'S AND REVIEWERS' COMMENTS

Editor’s comments

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

In addition to comments provided by the two reviewers, the please consider the following:

Comment

Line 26: Consider revision to "The study employed an exploratory qualitative design"

Response

The change has been effected in the revised manuscript. (line 26, pg 2).

Comment:

Line 26-27: It is enough to say "purposive sampling technique"

Response

The change has been effected in the new manuscript (line 26, pg 2).

Comment

Line 28: Write ‘8’ in word

Response:

The number ‘8’ has been written in full in the new manuscript (line 28, pg 2)

Comment:

Line 29: Consider changing "were sampled and interviewed" to just "were interviewed"

Response:

The change has been effected in the revised manuscript (line 29, pg 2).

Comment:

In the abstract, state the data analysis approach in a short sentence.

Response:

The data analysis approach has been mentioned in the abstract in the revised manuscript (line 31).

Comment

Line 32: Consider revising to: “The major reasons for discontinuation of infertility medical services included….”

Response

The change has been effected in the revised manuscript (line 32).

Comment

Line 37-39: It might be better to say the insight provided rather that say it will provide insight. The current statement sounds like a justification for the study, not a recommendation from the findings, as might be the intention of the authors.

Response

The change has been effected in the revised manuscript (line 37-38).

Comment

Line 94: This initial statement does not make your study population clear. Twenty couples ordinarily means 20 pairs of persons, making 40 persons.

Response

The term ‘couples’ has been changed to ‘patients’ in the revised manuscript.

Comment:

Also, please indicate that you did not interview both members of each couple pair, and why not.

Response:

None of the 20 respondents were from the same couple pair. The telephone calls were made to the number(s) provided by the couple-pair during their first visit. However, any of the partners who was available and willing to participate in the study was recruited.

Comment

Please ensure to remove any personal identifying information from your manuscript, including names of organizations where identifying them is not essential to the information being provided. You must justify the inclusion of names that identify any entity.

Response

Names of organizations that are not essential to the information being provided have been removed from the revised manuscript.

Comment

Concerning your suggestions on the approach to data collection, infertility is a sensitive issue and FGD may still not be the most appropriate fora for data collection, particularly when the proposed participants are currently experiencing infertility.

Response

Thank you for your comment regarding the approach to data collection we suggested as recommendation for further research. The suggestion of FGD has been removed from the revised manuscript.

Comment

In line with the comments of one of the reviewers, consider removing the word "subfertile" from your title.

Response

The term “subfertile” has been removed from the title of the revised manuscript.

Comment

Do pay attention to typographical and grammatical errors.

Response

The authors are grateful to the Editor for his constructive comments and suggestions in reshaping out manuscript.

The revised manuscript has been proofread by people and typographical and grammatical errors.

RESPONSE TO REVIEWER 1

Comment:

In the title you talk about choices that subfertile couples make, but I am not sure how representative the term couples is of the study population?

Response:

It is true that the female respondents were more than the male respondents. Throughout the study, it was observed that the males were less forthcoming when it comes to cooperating with treatment and willingness to participate in the study. This has largely been attributed to the cultural setting in African, which places the responsibility of childbirth on the doorsteps of women. This has been well-elaborated in the manuscript. As such, we have revised the term “couples” to “patients” in the title.

Comment:

Some small changes which would make some things clearer for me:

line 72, pg 4 - change to 'for infertility' instead of 'of infertility'

Response:

The change has been effected (line 74, pg 4).

Comment:

line 73, pg 4 - add Metropolis to Cape Coast, as you later refer to just 'the metropolis' this confused me, and then you later call it Cape Coast Metropolis

Response:

The change has been effected (line 82, page 4).

Comment:

line 76, pg 4 - to enable stakeholders 'to' develop (word missing)

Response:

The change has been effected (line 78, page 4).

Comment:

lines 94-96, pg 5 - I would like to see this more clearly, on first reading it appears you interviewed 20 couples, but you then say you interviewed 14 women and 6 men. Maybe be specific that you interviewed 20 clients, which were a combination of 14 women and 6 men - but were any of these couples?

Response:

The suggestion has been well noted and correction effected in the revised manuscript. Please refer to lines 96-97 on page 5.

On the question regarding whether any of the respondents were couples, the telephone calls were made to the number(s) provided by the couples during their first visit. However, any of the partners who was willing to participate in the study was recruited. As such, none of the 20 respondents were from the same couple pair.

Comment:

line 130 - pg 7 - who did the transcription? and also did you use a specific type of thematic analysis?

Response

Two of the authors inductively coded four of the transcripts (two from CIN and two from HP) independently. The initial codes were review6d by three of the authors for consistency before a consensus was reached on the codes and the coding system. The first author then coded all the transcripts using the coding system agreed upon (line 145-149, pg 8).

On the question of a specific type of thematic analysis, a thematic content analysis was used to analyze the data (line 143-144, pg 8).

Comment:

line 132, pg 7 - reword 'two of the authors coded few' this reads as though they coded a minimal amount - might be useful to say how many and which (HCP or clients).

Response:

Two of the authors inductively coded four of the transcripts (two from patients and two from the healthcare personnel). As such the changes have been effected in the revised manuscript. (lines 146-147).

Comment:

line 135, pg 7 - It feels more accurate to say that themes were identified than that they emerged.

Response:

We have changed the term “emerged” to “identified” in the revised manuscript (line 151, pg 8).

Comment:

line 138, pg 8 - I think you mean that you were maintaining confidentiality, the opposite to disclosing the identity of the participants?

Response:

The correction has been effected in the revised manuscript. (Please refer to page 8, line 134).

Comment:

line 190, pg 10 - 'live' birth (also line 430)

Response:

The correction has been effected. (line 212, page 12).

Comment:

line 433, pg 21 - you talk about internal and external pressures - which do you mean specifically?

Response:

The sentence has been clarified in the revised manuscript (line 457-458, pg 23).

Comment:

line 485, pg 24 - midst, not mist

Response:

The word has been spelt correctly in the revised manuscript. Line 518, page 27.

Comment

I really enjoyed reading this, thank you. And I think you have made some really important points, particularly about the abdication of responsibility of the male partners.

There has been much made of the 'delay' to treatment outcomes - do you have a sense, or data to indicate what sort of time frames that are contributing to the drop out of treatment?

I think that this article may need some editing for language and clarity, but the data support the conclusions and suggestions you have made for how services could be improved.

Response

Authors are grateful to the reviewer for her kind comments about our manuscript. We also thank her for the constructive comments which have made the revised manuscript better.

From the observations made in the study as well as responses from health professionals, a delay in expected outcome for about 1–3 months for males and 2-4 months for the females, usually caused them to abdicate treatment. We have included the time frames in the revised manuscript.

The manuscript has been proofread by people with English as their first language.

Reviewer #2: Review PONE-D-22-12329

This a very important qualitative interview study on why couples in Ghana discontinue fertility treatment (pharmacotherapy). A topic where we have very limited knowledge from low/middle income countries. Globally, infertility is one of the most frequent diseases among reproductive-aged women and men. In middle and low-income countries the access to fertility treatment is limited and is not affordable for many couples with infertility. The study is carefully conducted, data clearly presented and the manuscript is easy to follow.

I have a number of minor suggestions.

Terminology

I suggest to follow the terminology in the International Glossary on Infertility and Fertility Care, 2017 (Zegers-Hochschild et al., Human Reproduction, 2017). My suggestion is to use “infertility” as this is clearly defined (and not “subfertility” that is usually not well-defined); fertility care, fertility clinics, fertility treatment and in line with this fertility patients.

Throughout the manuscript is used both “clients” and “fertility patients”. I suggest to use only one term (fertility patients). Similarly, is used both “infertility” and “subfertility”. I suggest infertility as stated above.

Response:

We thank the reviewer for drawing our attention to this. We have replaced “subfertility” with “infertility” in the revised patients.

INTRODUCTION

Comment

Is well-written and provides a good overview. I suggest to include a few more papers on infertility in Sub-Saharan countries. Search e.g., for papers in Pubmed published by Silke Dyer, Johanne Sundby, Florence Naab and others and you will find papers e.g., on access to fertility care, the psychosocial impact of infertility, studies on the impact of male infertility, how fertility patients assess treatment. Some could probably also be included in the Discussion section.

Response

The recommended papers have been read as suggested. The introduction and the discussion sections have been updated accordingly.

MATERIALS AND METHODS

Comment

I suggest to add either a table or a short overall description of the study participants (besides their gender). For the fertility patients – e.g., age range, previous reproductive history (have child/children or not), previous treatment. For the health care professionals – e.g, number of years in fertility care. This info should be provided on a group level, so the study participants could not be identified.

Response

Tables indicating the overall description of study participants have been provided in the revised manuscript.

Comment

I suggest to put the paragraph on Ethical approval as the last section before Results.

Response

The changes have been effected in the revised manuscript

Comment

Please, provide a reference to the thematic analysis used.

Response

Reference has been provided in the revised manuscript.

Comment

The description of how you assigned codes to the interview transcripts is not a Result and should be placed in the M&M section.

Response

The changes have been effected as suggested.

RESULTS

I suggest you provide a table showing themes from interviews with fertility patients and with health care professionals, respectively. To help the reader to have an overview.

Otherwise the result section is easy to follow and quotes selected are illustrative for the theme.

Comment

In quotes, I would recommend not to mention e.g., name of fertility clinics in order not to reveal study participant identity.

Response

Names of fertility clinics have been removed from the revised manuscript.

Comment

I would prefer Psychological distress (p. 15 , line 299) instead of disturbances (which sounds closer to psychiatric disorders).

Response

The correction has been effected in the revised manuscript (line 323, page 18).

Comment

Discussion is relevant. I found it interesting that the fertility patients’ do not mentioning stigma as a reason for discontinuation, but it was mentioned by the health care professionals. Could this difference be discussed in short?

Response

The discussion on sigma has been updated in the revised manuscript (line 501-509, page 26).

Attachment

Submitted filename: Response to reviewers 1.docx

Decision Letter 1

Thomas Tischer

11 Aug 2022

PONE-D-22-12329R1Pharmacotherapy of infertility in Ghana: Why do infertile patients discontinue their fertility treatment?PLOS ONE

Dear Dr. Arhin,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please see "additional Editor comments" section below

Please submit your revised manuscript by Sep 25 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Thomas Tischer

Staff Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

  • We noticed that your study included 20 participants, however the "occupation" row in Table 1 adds up to 21 individuals. If it was possible to provide multiple answers to this questions, please indicate this. Otherwise, please ensure to correct the "occupation" row with the correct value

  • We noticed that in Table 1 there is a difference in the capitalization of "Male" vs "female"

  • Please check your other tables for similar inconsistencies (numbers and grammar)

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for the work you have done on this manuscript, it is an important field of study and crucial that we are exploring experiences of accessing healthcare across all populations and countries.

Reviewer #2: The authors have carefully revised the manuscript in accordance with comments from reviewers and AE. I have two additional minor comments:

1. Most places the author states "infertile patients" and fewer places "fertility patients" (e.g., Table 3, and in sub-heading line 205). I suggest to be consistent throughout the manuscript and use one term only. As previously mentioned, I prefer "fertility patients"; however, this is not a requirement.

2. I would avoid the term "drop-out" of fertility treatment, as "drop-out" could indicate something that just happened passively. Studies - including your own - clearly indicates that fertility patients who discontinue treatment has been actively through a decision-making process.

On p. 6, Sampling, I suggest e.g. to revise to "20 fertility patients who had discontinued treatment " and in Table 1 to change "drop-out time" to Treatment discontinuation. I am not sure whether it is discontinuation after 1-3 months of being in fertility treatment?

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Eleanor Molloy

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Oct 17;17(10):e0274635. doi: 10.1371/journal.pone.0274635.r004

Author response to Decision Letter 1


22 Aug 2022

Response to editor’s and reviewers’ comments

We are very much grateful to the editor and the reviewers for their meaning contributions towards reshaping of our manuscript.

Response to Editor’s comment

Comment: We noticed that your study included 20 participants, however the "occupation" row in Table 1 adds up to 21 individuals. If it was possible to provide multiple answers to this question, please indicate this. Otherwise, please ensure to correct the "occupation" row with the correct value.

Response: This was an error, and correction has been effected in the revised manuscript.

Comment: We noticed that in Table 1 there is a difference in the capitalization of "Male" vs "female"

Response: Appropriate changes have been made to ensure consistency in the revised manuscript.

Comment: Please check your other tables for similar inconsistencies (numbers and grammar).

Response: Other tables have been checked and necessary changes effected in the revised manuscript.

Response to reviewer 2 comments

Comment: Most places the author states "infertile patients" and fewer places "fertility patients" (e.g., Table 3, and in sub-heading line 205). I suggest to be consistent throughout the manuscript and use one term only. As previously mentioned, I prefer "fertility patients"; however, this is not a requirement.

Response: We are grateful to you for drawing our attention to this error. The necessary corrections have been effected to ensure uniformity and consistency. However, the term ‘infertile patients’ has been maintained in the revised manuscript.

Comment: I would avoid the term "drop-out" of fertility treatment, as "drop-out" could indicate something that just happened passively. Studies - including your own - clearly indicates that fertility patients who discontinue treatment has been actively through a decision-making process.

On p. 6, Sampling, I suggest e.g. to revise to "20 fertility patients who had discontinued treatment " and in Table 1 to change "drop-out time" to Treatment discontinuation. I am not sure whether it is discontinuation after 1-3 months of being in fertility treatment?

Response: The suggested corrections have been effected accordingly in the revised manuscript.

On the issue of discontinuation, the 1-3 months means the average duration after which the patients discontinued their treatment.

Attachment

Submitted filename: RESPONSE TO THE EDITOR AND REVIEWERS COMMENTS.docx

Decision Letter 2

George Vousden

1 Sep 2022

Pharmacotherapy of infertility in Ghana: Why do infertile patients discontinue their fertility treatment?

PONE-D-22-12329R2

Dear Dr. Arhin,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

George Vousden

Staff Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

George Vousden

7 Oct 2022

PONE-D-22-12329R2

Pharmacotherapy of infertility in Ghana: Why do infertile patients discontinue their fertility treatment?

Dear Dr. Arhin:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. George Vousden

Staff Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (DOCX)

    Attachment

    Submitted filename: Response to reviewers 1.docx

    Attachment

    Submitted filename: RESPONSE TO THE EDITOR AND REVIEWERS COMMENTS.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES